Long-Term Follow-Up of Gemogenovatucel-T (Vigil) Survival and Molecular Signals of Immune Response in Recurrent Ovarian Cancer

Aim: To determine the relationship between gene expression profile (GEP) and overall survival (OS) by NanoString following treatment with Vigil. Patients and Methods: Recurrent ovarian cancer patients (n = 21) enrolled in prior clinical trials. Results: GEP stratified by TIS(HIGH) vs. TIS(LOW) demon...

Descripción completa

Detalles Bibliográficos
Autores principales: Rocconi, Rodney P., Stanbery, Laura, Madeira da Silva, Luciana, Barrington, Robert A., Aaron, Phylicia, Manning, Luisa, Horvath, Staci, Wallraven, Gladice, Bognar, Ernest, Walter, Adam, Nemunaitis, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402348/
https://www.ncbi.nlm.nih.gov/pubmed/34452019
http://dx.doi.org/10.3390/vaccines9080894

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402348/
https://www.ncbi.nlm.nih.gov/pubmed/34452019
http://dx.doi.org/10.3390/vaccines9080894

Ejemplares similares